Li Zhiji, a 36-year-old volunteer, receives the recombinant novel coronavirus (COVID-19) vaccine inoculation in Wuhan, Central China’s Hubei province, on March 24, 2020. The first batch of 108 volunteers arrived in Wuhan on Tuesday to receive inoculations after a clinical trial of the novel coronavirus vaccine in China kicked off last Monday. All recipients will be under a 14-day quarantine after vaccination. [Photo by Zhu Xingxin/chinadaily.com.cn]
Wang Li, a 45-year-old volunteer, receives the recombinant novel coronavirus (COVID-19) vaccine inoculation in Wuhan, Central China’s Hubei province, on March 24, 2020. [Photo by Zhu Xingxin/chinadaily.com.cn]
Guo Xin, a 41-year-old volunteer, receives the recombinant novel coronavirus (COVID-19) vaccine inoculation in Wuhan, Central China’s Hubei province, on March 24, 2020. [Photo by Zhu Xingxin/chinadaily.com.cn]
A medical worker extracts the recombinant novel coronavirus (COVID-19) vaccine into a syringe in Wuhan, Central China’s Hubei province, on March 24, 2020. [Photo by Zhu Xingxin/chinadaily.com.cn]
A medical worker injects the recombinant novel coronavirus (COVID-19) vaccine into a volunteer recipient in Wuhan, Central China’s Hubei province, on March 24, 2020. [Photo by Zhu Xingxin/chinadaily.com.cn]
Vials contain the recombinant novel coronavirus (COVID-19) vaccine being tested in Wuhan, Central China’s Hubei province, on March 24, 2020. [Photo by Zhu Xingxin/chinadaily.com.cn]
[disclaimer] the above article is reprinted from the Internet, which is intended to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity; if the copyright unit or individual of the manuscript is unwilling to issue it on the website, please contact us or call us within two weeks.
